Hangzhou Jianhai Technology, a China-based healthcare management software provider backed by artificial intelligence technology producer iFlytek, has secured RMB150m ($23m) in series B funding, DealStreetAsia reported yesterday.
Venture capital firm Sequoia Capital China led the round, which included Source Code Capital and Sherpa Healthcare Partners, while Probe Capital was financial adviser for the transaction.
Jinhai Technology has created a software platform that utilises artificial intelligence to help inform care for patients once they have been discharged from hospital.
Sherpa Healthcare Partners and Source Code Capital supplied $9m in series A3 funding for the company in September 2020 according to DealStreetAsia, which named iFlytek unit iFlytek Venture Capital SVB Capital and HaiBang Capital as earlier investors.
